2023-01-24 13:36:05

The FDA's power to approve drugs faces sweeping challenge in lawsuit seeking to pull abortion pill from U.S. market

By Spencer Kimball

Key Points

  • Anti-abortion physicians are suing to overturn the FDA's approval of mifepristone, which dates back more than two decades.
  • Mifepristone used in combination with misoprostol is the most common way to terminate a pregnancy in the U.S.
  • If the lawsuit prevails, mifepristone would no longer be available in the U.S. market and the FDA's drug approval powers would be weakened.

Mifepristone (Mifeprex) and Misoprostol, the two drugs used in a medication abortion, are seen at the Women's Reproductive Clinic, which provides legal medication abortion services, in Santa Teresa, New Mexico, on June 17, 2022.

Robyn Beck | AFP | Getty Images

The Food and Drug Administration is squaring off with anti-abortion physicians in an unprecedented legal challenge to its more than two-decade-old approval of a pill used to terminate early pregnancies.

The Alliance for Hippocratic Medicine asked a federal district court in Dallas late last year to declare the FDA approval unlawful and completely remove the abortion pill from the U.S. market.

Continue read on cnbc.com

Logo Bloomberg
PoliticsBy Jennifer Jacobs2023-01-22 18:40:54
President Joe Biden is issuing a memorandum aimed at protecting access to mifepristone, a drug used in medication abortion, Vice President Kamala Harris said...

Logo U.S. News & World Report
PoliticsBy Health Day2023-01-19 12:52:00
By Denise Mann HealthDay Reporter THURSDAY, Jan. 19, 2023 (HealthDay News) -- In the wake of the U.S. Supreme Court's decision to overturn Roe v. Wade in...

Logo GlobeNewswire
SciencePress Release2023-01-23 18:25:00
Announced Earlier Today -Notice Received from ANDA Filer for FIRDAPSE CORAL GABLES, Fla., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc....

Logo EIN Presswire
HealthPress Release2023-01-24 11:53:33
Uterine Cancer Drugs Market Uterine cancer is one of the most common gynecologic malignancy among female cancer patients. BURLINGAME, CA, UNITED STATES,...

Logo U.S. News & World Report
PoliticsBy Kaiser Health News2023-01-23 22:00:22
By Julie Rovner | KHN Anti-abortion advocates are pressing for expanded abortion bans and tighter restrictions since the Supreme Court overturned the...

Logo The Business Journals
Politics2023-01-23 23:11:08
Cipla Ltd. wants to make generic versions of drugmaker Fennec's lone product.

Logo EIN Presswire
HealthPress Release2023-01-23 17:53:41
Emergen Research Logo Rising incidence of Acute Myeloid Leukemia (AML) is a key factor driving FLT3 inhibitors market revenue growth FMS Like Tyrosine kinase...

Logo PR Newswire
HealthPress Release2023-01-24 13:07:00
MORRISVILLE, N.C, Jan. 24, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions that advance a wide variety of...

Logo U.S. News & World Report
PoliticsBy Associated Press2023-01-23 19:15:55
ALBUQUERQUE, N.M. (AP) New Mexico s top prosecutor on Monday asked the state Supreme Court to nullify abortion ordinances that local elected officials have...

Logo PR Newswire
HealthPress Release2023-01-23 22:00:00
DUBLIN, Jan. 23, 2023 /PRNewswire/ -- The "Ovarian Cancer Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented...

HealthBy Alice Miranda Ollstein2023-01-05 18:24:03
The FDA on Tuesday denied two citizen petitions related to mifepristone the first of two pills used to terminate a pregnancy declining to loosen or tighten...

Logo GlobeNewswire
SciencePress Release2023-01-23 14:22:00
NEW HAVEN, Conn., Jan. 23, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the Company or Bioasis ), a multi-asset rare and...

Logo PR Newswire
HealthPress Release2023-01-24 13:00:00
FDA's Decision Forthcoming for Innovative Test with Agency's Breakthrough Device Designation ST. LOUIS, Jan. 24, 2023 /PRNewswire/ -- Geneoscopy Inc., a life...

Logo BBC
ScienceBy Https://Www Facebook Com/Bbcnews2023-01-23 19:29:37
By Malcolm Prior BBC News Rural Affairs team The UK government has again given emergency authorisation for the use of a type of pesticide banned because of...

Logo Benzinga
Business / FinanceBy Pr Newswire2023-01-24 12:36:00
Treatment IDE Will Provide Opportunity to Treat Additional Patients in the US SAN RAMON, Calif., Jan. 24, 2023 /PRNewswire/ -- BioVentrix, Inc., a privately...

Logo GlobeNewswire
SciencePress Release2023-01-24 12:30:00
SAN DIEGO, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the...

PoliticsBy Claire Rush2023-01-23 21:59:57
PORTLAND, Ore. Oregon is launching a new abortion hotline offering free legal advice to callers, moving to further defend abortion access after the U.S....

Logo The Business Journals
Politics2023-01-23 16:57:20
Cipla Ltd. wants to make generic versions of Research Triangle Park drugmaker Fennec's lone product.

Logo PR Newswire
HealthPress Release2023-01-14 01:39:00
NEW YORK, Jan. 13, 2023 /PRNewswire/ -- Today, Danco Laboratories (Danco) filed a motion to intervene in Alliance for Hippocratic Medicine v. FDA, a lawsuit...

Logo RTTNews
PoliticsBy Joji Xavier2023-01-23 13:24:22
On what would have been the 50th anniversary of the Supreme Court's decision in Roe v. Wade, President Joe Biden issued an order to further protect access to...